Do you have PolyMyalgia Rheumatica #PMR?
🚶🏽#Exercise & incorporating #physicalactivity into your day has health benefits
😀Mood
🦴Bones
💪🏽Muscles
➕More
Here's a new guide to help you, co-produced by patients & specialists, supported by @PMRGCAuk
👉🏽https://t.co/hHdFMeta7d
The #TOCSTOP research (@VanessaQuick3 et al) clearly shows that for #GCA patients who receive a year's treatment of tocilizumab - 1/3 relapse by 1 year and 1/2 relapse by 2 years https://t.co/PFbIiouF0s. GCA patients need greater access to this drug.
@IhabFathiSulima Ultrasound should be the first test for #GCA diagnosis if available. TAB would v likely be an unnecessary / invasive test in this florid case, plus unlike ultrasound it would not give additional info about large vessel #LVV involvement
https://t.co/yNZu0AChMy.
@ward_round @OGdukeneurosurg In Europe and increasingly in the states ultrasound is the first test for GCA and biopsy is reserved for uncertain cases
https://t.co/6wUZmlelkZ
https://t.co/yNZu0AChMy.
@ward_round @OGdukeneurosurg Temporal arteritis is an out dated but still used name for GCA, as the condition affects a much wider number of arteries in many patients. A significant proportion have large vessel involvement including the aorta and its large branches such as the axillaries.
Delighted to announce that TOC STOP, a national service evaluation of #GCA patients that have completed a course of #Tocilizumab has recruited 379 patients from 40 Trusts across England and Wales. @PMRGCAuk@RheumatologyUK#ENRAD@NICEguidance
Advice for new fellows:
Visit 1: Dx- fibromyalgia
Visit 2: MSKUS w/o synovitis
Visit 3: carpal tunnel syndrome
Visit 4: carpal tunnel injection
Visit 5 today: clinical and sonographic synovitis across MCPs and PIPs
Things change. Never put someone firmly in one box
#RheumTwitter
Rheum led FTPs increase rates of secure diagnosis, reduce biopsy rates and reduce sight loss in GCA all for less cost and less admission days. Pushing GCA suspects to A/E will reverse all that.
Worrying: This doesn’t follow BSRs own GCA guideline 2020 “Pts should be evaluated by a specialist ideally on the same working day and in all cases within 3 working days” and may deincentivise Rheum depts to set up GCA fast track pathways as a 1 day rule will feel unachievable
The British Society for #Rheumatology@RheumatologyUK developed guidance to help ensure right patients are seen promptly by UK specialist
Getting It Right First Time #GIRFT
👉🏽https://t.co/noz6kLc7Uv
...including conditions not to be referred to rheumatology
👇🏽
@profbdasgupta@DrAiLynTan@RheumatologyUK@dalia_ludwig@alwinuk Rheum led FTPs increase rates of secure diagnosis, reduce biopsy rates and reduce sight loss in GCA all for less cost and less admission days. Pushing GCA suspects to A/E will reverse all that.
@profbdasgupta@DrAiLynTan@RheumatologyUK@dalia_ludwig@alwinuk Worrying: This doesn’t follow BSRs own GCA guideline 2020 “Pts should be evaluated by a specialist ideally on the same working day and in all cases within 3 working days” and may deincentivise Rheum depts to set up GCA fast track pathways as a 1 day rule will feel unachievable
2020 Rheumatology Year in Review-- Read our top news items that rheumatologists should recollect and integrate into clinical standards for 2021 and beyond.
https://t.co/QisCpdcLEa